Medical Device Manufacturing License in the UK: What You Need If you've searched for a "medical device manufacturing licence," you've probably found conflicting answers. Here's the direct one: the UK does not issue a single, universal licence that authorises you to manufacture and sell medical devices. There's no equivalent of a medicines manufacturing authorisation that you simply apply for and receive.

Instead, market access depends on several interlocking requirements: how your product is classified, which conformity assessment route applies, your quality management controls, your responsibilities as the legal manufacturer, and registration with the Medicines and Healthcare products Regulatory Agency (MHRA).

This article is written for UK-based and overseas manufacturers, contract manufacturers, importers, and any business planning to place devices on the Great Britain or Northern Ireland market. We'll walk through manufacturing permission versus MHRA registration, UKCA and CE marking, the UK Responsible Person role, and the post-market obligations that continue long after launch.

Key Takeaways

  • Setting up a UK company or factory doesn't authorise any device for sale on its own.
  • The legal manufacturer stays responsible for the device even when production is outsourced.
  • Device classification determines your conformity-assessment route and whether a UK Approved Body is required.
  • Rules differ between Great Britain and Northern Ireland, and vary further for IVDs, software, and custom-made devices.

What Does a "Medical Device Manufacturing Licence" Mean in the UK?

The phrase is misleading. MHRA regulates medical devices through classification, conformity assessment, and registration — but it generally does not issue one all-purpose manufacturing licence. MHRA has explicitly stated that registration itself is not accreditation, certification, approval, or endorsement of your product (MHRA, 2026).

The Compliance Components You Actually Need

Rather than a single licence, compliance is built from several pieces:

  • Legal-manufacturer status — confirming who holds responsibility for the device
  • Device classification — which risk category your product falls into
  • Conformity assessment — the evidence and testing route required
  • Technical documentation — the file proving the device is safe and performs as intended
  • Quality management system (QMS) controls — governing design, production, and change
  • Product marking — UKCA, CE, or CE/UKNI depending on the market
  • MHRA registration — the administrative step before market placement

Business permissions are separate from product permissions. Planning consent, environmental permits, workplace-safety approvals, or controlled-substance licensing may apply to your physical premises — these sit entirely outside the device-approval process and need checking independently with local authorities.

Who Counts as the Legal Manufacturer?

Under the UK Medical Devices Regulations 2002, the "manufacturer" is whoever places the product on the market under their own name — not necessarily whoever physically builds it. This includes a business that:

  • Designs a device and has it built by a third party
  • Rebrands a finished device under its own label
  • Makes significant modifications to an existing device

Contract manufacturers and assemblers often aren't the legal manufacturer. That doesn't let them off the hook, though. They still need documented controls covering:

  • Supplier qualification
  • Traceability
  • Production and inspection records
  • Non-conformity handling
  • Audit readiness

The legal manufacturer will need that evidence to support the technical file.

Legal manufacturer and contract manufacturer responsibility comparison

Which Regulatory Requirements Apply Before You Manufacture or Sell?

Confirm the product actually qualifies as a medical device. Some products sit in a grey zone between devices, cosmetics, consumer goods, and medicinal products.

MHRA's borderline-products guidance is the reference point when the principal mode of action isn't obvious: software that analyses symptoms, wellness-adjacent wearables, and combination products are common examples.

Classification Drives Everything Downstream

For general medical devices, classification depends on intended purpose, invasiveness, duration of use, whether the device is active or implantable, and the level of patient risk involved:

General-device class MHRA's broad risk description
I Generally low risk
IIa Generally medium risk
IIb Generally medium risk
III Generally high risk

IVDs follow a separate classification system, so don't assume the same rules transfer across.

Quality Management and Technical Documentation

A functioning QMS should cover:

  • Design controls and document control
  • Supplier and production controls
  • Complaints handling plus corrective and preventive action
  • Training and change management

Most manufacturers build that system to ISO 13485. Confirm the precise legal requirement for your device and conformity route before treating the standard as mandatory in every case.

Your technical documentation file typically needs to include:

  • Device description and intended purpose
  • Classification rationale
  • Design and manufacturing information
  • Risk-management file
  • Verification and validation evidence
  • Clinical or performance evaluation
  • Labelling and instructions for use
  • Post-market surveillance plans

Conformity Assessment and the CE/UKCA Question

Non-sterile, non-measuring Class I devices can often self-declare for UKCA marking. Sterile devices, measuring devices, and anything above Class I generally need a UK Approved Body to review your evidence, manufacturing processes, and QMS before you can affix a UKCA mark.

CE-marked devices aren't locked out of Great Britain overnight, but the acceptance periods vary by certification basis:

CE conformity basis GB placement cutoff
General devices certified under earlier EU MDD/AIMDD rules Earlier of certificate expiry or 30 June 2028
IVDs under earlier EU IVDD rules Earlier of certificate expiry or 30 June 2030
General devices under EU MDR; IVDs under EU IVDR 30 June 2030

A proposal for indefinite CE recognition was opened for consultation in 2026, but that remains a proposal, not a confirmed rule, according to MHRA's published transition timelines. Always check GOV.UK before relying on a cutoff date; these transitional arrangements have shifted before and can shift again.

Northern Ireland is different again. UKCA alone is not accepted there; you need CE marking or a combined CE/UKNI mark.

How to Obtain the Required UK Registrations and Compliance Documents

Think of this as a sequence, not a single application form.

  1. Define your scope. Identify the intended market (Great Britain, Northern Ireland, or both), confirm who the legal manufacturer is, and map out your economic operators.
  2. Classify before you spend. Work out the classification and run a regulatory-gap assessment before committing to testing, facility expansion, or labelling changes. Document your classification rationale, including any related device families or accessories.
  3. Select your conformity-assessment route. Where a UK Approved Body is required, start early. Their queues can be long. If you already hold EU or international certificates, check how these coordinate with your UK route rather than duplicating work unnecessarily.
  4. Build your document-readiness checklist. This should cover your QMS, technical file, risk-management documentation, clinical or performance evidence, manufacturing records, labels, instructions for use, and your declaration of conformity.
  5. Appoint a UK Responsible Person (UKRP) if you're based overseas. The UKRP ensures your technical documentation and conformity assessment actually exist, liaises with MHRA, supports registration, and relays vigilance reports back to you.
  6. Register with MHRA through DORS. The responsible economic operator creates an account in the Device Online Registration System, submits accurate manufacturer and device information, and pays the applicable fee.

Six-step UK medical device registration and compliance process

What Registration Actually Costs and Covers

For the 2026–27 charging year, MHRA's published fee is £300 per year per chargeable GMDN Level 2 category (or Level 1 where no Level 2 exists). New registrations mid-year are charged pro rata (MHRA registration guidance). That's a per-category fee, not a per-device fee, which matters if you're registering a broad product range.

A device isn't registered until MHRA confirms it. Submitting the form isn't the finish line. Registration, once confirmed, still doesn't replace conformity assessment, certification, or evidence that your device is safe and performs as intended. It's an administrative step that sits alongside everything else, not instead of it.

How Should a Manufacturer Prepare Its UK Operations?

Getting your paperwork approved is only half the job. Your facility and production processes need to match what's written in your technical documentation.

Facility and Supplier Controls

Expect to demonstrate:

  • Controlled production processes with competent, trained personnel
  • Validated or verified equipment where relevant to your device type
  • Incoming-material and environmental controls appropriate to risk
  • Batch or serial traceability records

If you outsource any part of production, written quality agreements matter. They should cover:

  • Audit rights
  • Change notification
  • Non-conformity handling
  • Clear responsibility for critical components or sterilisation processes

Gaps here are a common reason technical files fall apart under Approved Body scrutiny.

Post-Market Obligations Don't Stop at Launch

Strengthened post-market surveillance (PMS) requirements apply to devices placed on the market from 16 June 2025 onward. Your PMS plan should be proportionate to risk, continually collect safety and performance data, and document what you did with that information (MHRA PMS guidance).

General-device class PMS document/frequency
I PMS report
IIa Periodic safety update report, first within two years, then every two years
IIb and III Periodic safety update report, first within one year, then annually

Beyond reporting, you'll need processes for complaint handling, trend monitoring, field safety corrective actions, and recalls where necessary.

Common Failure Points Worth Avoiding

  • Assuming EU compliance automatically covers Great Britain
  • Appointing a UKRP without checking they hold sufficient authority
  • Making inconsistent product claims across markets
  • Registering with MHRA before your documentation is actually ready
  • Treating a QMS certificate as a substitute for proven product conformity

MHRA's enforcement record illustrates why this matters. In one prosecuted case, enteral-feeding pumps were marketed and used with invalid CE markings.

Those devices had not undergone the required assessments, clinical evaluation, or safety testing. The result was safety alerts, recalls, and criminal convictions—the real-world cost of treating marking as a formality rather than evidence of actual conformity.

Medical device noncompliance consequences from invalid CE marking

Cost and Timeline Drivers

The main cost and timeline drivers are:

  • Device class and whether third-party assessment applies
  • Testing and clinical evidence requirements
  • QMS remediation, if gaps exist
  • UKRP service costs
  • Registration fees
  • Facility controls and insurance
  • The quality of your initial submission (poor documentation means more review cycles)

This is also where the business side of expansion matters. VJM Global supports overseas businesses with company-formation coordination, accounting, and tax-compliance work that typically surrounds expansion into the UK.

That is a different lane from regulatory approval. Specialist regulatory consultants and UK Approved Bodies handle technical conformity assessment and device approvals themselves.

Conclusion

A single manufacturing licence is only part of market access. What matters is the full mix of regulatory, quality, registration, and operational obligations that apply to your device and chosen market.

Before you commit to manufacturing or launch, confirm:

  • Product classification
  • Target territory
  • Legal-manufacturer status
  • Conformity assessment route
  • Whether you need a UKRP

Transitional rules on CE and UKCA acceptance have shifted before. Check current MHRA and GOV.UK guidance rather than older summaries, including this one.

Frequently Asked Questions

Is a medical device manufacturing licence required in the UK?

There is no single universal manufacturing licence. Instead, you need applicable conformity assessment, QMS controls, product marking, MHRA registration, and any premises-specific permissions relevant to your facility.

Do all medical devices need MHRA registration?

Devices placed on the Great Britain market generally require registration before placement, while Northern Ireland follows separate rules involving EUDAMED and specific categories like custom-made devices. Check current MHRA guidance for any exemptions relevant to your device.

Does an overseas medical device manufacturer need a UK Responsible Person?

Yes. A manufacturer established outside the UK that places devices on the GB market must designate a single UKRP. The UKRP confirms documentation exists, registers devices, liaises with MHRA, and relays vigilance reports.

What is the difference between UKCA and CE marking for medical devices?

UKCA is tied to the Great Britain route, while CE marking remains accepted under specified transitional arrangements with set cutoff dates. Northern Ireland requires CE or combined CE/UKNI marking instead. Always verify current deadlines before relying on either.

How long does UK medical device registration take?

The MHRA submission stage itself can be relatively quick, but overall market entry is usually driven by classification work, QMS readiness, evidence gathering, and conformity assessment, not the registration form itself.

Can a company manufacture medical devices in the UK without UKCA marking?

Manufacturing and placing a device on the market are different things. You can manufacture without UKCA marking, but you generally can't supply the device on the Great Britain market until UKCA, accepted CE marking, or another applicable route is in place.